BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 26806101)

  • 41. Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait.
    Khan Z; Ahmad S; Al-Sweih N; Mokaddas E; Al-Banwan K; Alfouzan W; Al-Obaid I; Al-Obaid K; Asadzadeh M; Jeragh A; Joseph L; Varghese S; Vayalil S; Al-Musallam O
    PLoS One; 2019; 14(5):e0216250. PubMed ID: 31042770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
    Aquino VR; Lunardi LW; Goldani LZ; Barth AL
    Braz J Infect Dis; 2005 Oct; 9(5):411-8. PubMed ID: 16410893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil.
    Moretti ML; Trabasso P; Lyra L; Fagnani R; Resende MR; de Oliveira Cardoso LG; Schreiber AZ
    Med Mycol; 2013 Apr; 51(3):225-30. PubMed ID: 22920712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
    Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
    Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients.
    Wu PF; Liu WL; Hsieh MH; Hii IM; Lee YL; Lin YT; Ho MW; Liu CE; Chen YH; Wang FD
    Emerg Microbes Infect; 2017 Oct; 6(10):e87. PubMed ID: 29018251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changing epidemiology of candidaemia in Australia.
    Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S;
    J Antimicrob Chemother; 2017 Apr; 72(4):1103-1108. PubMed ID: 28364558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.
    Deorukhkar SC; Saini S
    Infect Disord Drug Targets; 2016; 16(1):63-8. PubMed ID: 26648186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E; Hammarström H; Ataollahy N; Kondori N
    Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Emergence of Candida parapsilosis candidemia at Cochin hospital. Characterization of isolates and search for risk factors].
    Paugam A; Baixench MT; Taieb F; Champagnac C; Dupouy-Camet J
    Pathol Biol (Paris); 2011 Feb; 59(1):44-7. PubMed ID: 20889268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region.
    Tan TY; Hsu LY; Alejandria MM; Chaiwarith R; Chinniah T; Chayakulkeeree M; Choudhury S; Chen YH; Shin JH; Kiratisin P; Mendoza M; Prabhu K; Supparatpinyo K; Tan AL; Phan XT; Tran TT; Nguyen GB; Doan MP; Huynh VA; Nguyen SM; Tran TB; Van Pham H
    Med Mycol; 2016 Jul; 54(5):471-7. PubMed ID: 26868904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: An experience in a tertiary hospital in mid-Taiwan.
    Tseng TY; Chen TC; Ho CM; Lin PC; Chou CH; Tsai CT; Wang JH; Chi CY; Ho MW
    J Microbiol Immunol Infect; 2018 Aug; 51(4):552-558. PubMed ID: 28625801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.
    Li Y; Du M; Chen LA; Liu Y; Liang Z
    Mycopathologia; 2016 Aug; 181(7-8):485-95. PubMed ID: 26994763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Candidaemia in Sweden: a nationwide prospective observational survey.
    Ericsson J; Chryssanthou E; Klingspor L; Johansson AG; Ljungman P; Svensson E; Sjölin J
    Clin Microbiol Infect; 2013 Apr; 19(4):E218-21. PubMed ID: 23331511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
    Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An investigation of Candida species isolated from blood cultures during 17 years in a university hospital.
    Kazak E; Akın H; Ener B; Sığırlı D; Özkan Ö; Gürcüoğlu E; Yılmaz E; Çelebi S; Akçağlar S; Akalın H
    Mycoses; 2014 Oct; 57(10):623-9. PubMed ID: 24934185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
    Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
    Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals.
    Goemaere B; Becker P; Van Wijngaerden E; Maertens J; Spriet I; Hendrickx M; Lagrou K
    Mycoses; 2018 Feb; 61(2):127-133. PubMed ID: 29024057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt.
    Hegazi M; Abdelkader A; Zaki M; El-Deek B
    J Infect Dev Ctries; 2014 May; 8(5):624-34. PubMed ID: 24820467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes.
    Tsai MH; Hsu JF; Yang LY; Pan YB; Lai MY; Chu SM; Huang HR; Chiang MC; Fu RH; Lu JJ
    Sci Rep; 2018 Oct; 8(1):15239. PubMed ID: 30323257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.